- Home
- FVR vs RCEL Comparison
FVR vs RCEL Comparison
Compare FVR & RCEL Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- FVR
- RCEL
- Stock Information
- Founded
- FVR 2016
- RCEL N/A
- Country
- FVR United States
- RCEL United States
- Employees
- FVR N/A
- RCEL N/A
- Industry
- FVR
- RCEL Medical/Dental Instruments
- Sector
- FVR
- RCEL Health Care
- Exchange
- FVR NYSE
- RCEL Nasdaq
- Market Cap
- FVR 227.7M
- RCEL 161.5M
- IPO Year
- FVR 2024
- RCEL N/A
- Fundamental
- Price
- FVR $12.48
- RCEL $5.42
- Analyst Decision
- FVR Hold
- RCEL Strong Buy
- Analyst Count
- FVR 5
- RCEL 4
- Target Price
- FVR $16.80
- RCEL $16.50
- AVG Volume (30 Days)
- FVR 356.6K
- RCEL 316.4K
- Earning Date
- FVR 08-15-2025
- RCEL 08-07-2025
- Dividend Yield
- FVR 6.86%
- RCEL N/A
- EPS Growth
- FVR N/A
- RCEL N/A
- EPS
- FVR N/A
- RCEL N/A
- Revenue
- FVR $60,901,000.00
- RCEL $71,661,000.00
- Revenue This Year
- FVR $18.42
- RCEL $57.16
- Revenue Next Year
- FVR $6.26
- RCEL $36.69
- P/E Ratio
- FVR N/A
- RCEL N/A
- Revenue Growth
- FVR 15.85
- RCEL 41.35
- 52 Week Low
- FVR $10.61
- RCEL $4.71
- 52 Week High
- FVR $19.76
- RCEL $14.16
- Technical
- Relative Strength Index (RSI)
- FVR N/A
- RCEL 43.61
- Support Level
- FVR N/A
- RCEL $5.11
- Resistance Level
- FVR N/A
- RCEL $5.55
- Average True Range (ATR)
- FVR 0.00
- RCEL 0.31
- MACD
- FVR 0.00
- RCEL 0.10
- Stochastic Oscillator
- FVR 0.00
- RCEL 69.61
About FVR FRONTVIEW REIT INC
FrontView REIT Inc is an internally managed net-lease REIT that is experienced in acquiring, owning, and managing out parcel properties that are net-leased to a diversified group of tenants. The tenants of the company include service-oriented businesses, such as restaurants, cellular stores, financial institutions, automotive stores and dealers, medical and dental providers, pharmacies, convenience and gas stores, car washes, home improvement stores, grocery stores, professional services as well as general retail tenants.
About RCEL Avita Medical Inc.
Avita is a single product company. Its RECELL system is an innovative burn treatment device which creates Spray-on Skin from a small skin sample within 30 minutes, thus avoiding or reducing the need for skin grafts. It's approved for the treatment of adult and paediatric patients in the US and an expanded indication for soft-tissue reconstruction. It is currently in roll-out across the approximately 136 US burn centers. Despite having product approval in Australia, Europe, Canada, and China, Avita is not actively marketing in those territories and focussing instead on the US region. However, it is expected to launch in Japan via distribution partner Cosmotec in second-half fiscal 2022. Avita is domiciled, and has its primary listing, in the US.